Endocrine-Related Cancer

Papers
(The H4-Index of Endocrine-Related Cancer is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Acknowledgement to reviewers95
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs73
Prognostic of recurrence and survival in poorly differentiated thyroid cancer57
Celebrating the 80th anniversary of hormone ablation for prostate cancer55
Acknowledgement to reviewers53
Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients47
Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas44
Identifying metastatic renal cell carcinoma in thyroid fine-needle aspirates by molecular testing41
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications40
Targeting growth hormone in cancer: future perspectives38
Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells38
ERRATUM: Roles of the HOXA10 gene during castrate-resistant prostate cancer progression36
Chemokines with CXC motif and their receptors in neuroendocrine neoplasms36
Refining long-term surveillance requirements in patients with differentiated thyroid cancer31
Update on the genetics of paragangliomas31
The genetic changes in 11p15.5-related pheochromocytomas and paragangliomas30
CORRIGENDUM: GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts30
Radioiodine treatment: an historical and future perspective28
Metabolically active brown adipose tissue in PPGL: an observational cohort study28
MicroRNA regulation of the serine synthesis pathway in endocrine-resistant breast cancer cells28
Genistein induces endocrine resistance in human breast cancer by suppressing H3K27 trimethylation27
Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet27
Differential activity of specific inhibitors of transcription regulating cyclin-dependent kinases in thyroid cancer cells25
FAM64A contributes to ovarian cancer proliferation and metastasis by suppressing TWIST1 ubiquitination degradation24
CCL2 expression predicts clinical outcomes and regulates E-cadherin and angiogenesis in pituitary tumours24
Peptide receptor radionuclide therapy in malignant insulinoma24
0.0576171875